BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 31, 2001
View Archived Issues
FDA approves insulin analogue for pump therapy
Read More
Positive phase I/II AlloMune results for end-stage lymphoma
Read More
Kyowa Hakko develops new antibody technology
Read More
GeneProt delivers potential protein candidates to Novartis
Read More
Preparation and use of new thienopyrimidinediones discovered at AstraZeneca
Read More
Uriach researchers identify selective COX-2 inhibitors with antiinflammatory activity
Read More
Schering discloses new series of antiangiogenic agents
Read More
Novel epothilone derivatives from Schering act as microtubule-stabilizing agents
Read More
Vancomycin analogues with activity against enterococci and staphylococci
Read More
Inhibitors of shikamate pathway enzyme under development at Arrow as novel antibiotics
Read More
Design and preclinical evaluation of a new class of bacterial peptide deformylase inhibitors
Read More
Oxapenem beta-lactamase inhibitors reported at ICAAC to extend spectrum of cephalosporins
Read More
MitoKor and Pfizer extend mitochondrial dysfunction collaboration
Read More
ISV-401 enters phase II trials for bacterial conjunctivitis
Read More
Schering and MorphoSys enter therapeutic and diagnostic R&D agreement
Read More
AHP and Elan form sleep disorder alliance
Read More
Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503
Read More
Celera and Syrrx enter structural proteomics collaboration
Read More